Investigational Drug Shows Promise in Myotonic Dystrophy Type 1
(MedPage Today) -- Investigational zeleciment basivarsen (z-basivarsen) led to functional improvement in patients with myotonic dystrophy type 1 (DM1), data from the phase I/II ACHIEVE trial suggested. The analysis evaluated whether a larger group...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.